Looks for people with untreated hepatitis B, C or D in South-East Austria
Reviews past test results to find people with hepatitis, then invites them to clinic.
Plain-language title generated from the registry record
Registry title: Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
Key facts
- Where
- Graz, AustriaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people in South-East Austria with a detectable hepatitis C virus (HCV) or hepatitis B virus (HBV) in their blood. They are invited to talk about hepatitis treatment.
- Sex
- All sexes can join.
- Disease stage
- HCV group: detectable HCV RNA in the blood at the latest check. HBV group: detectable HBV RNA in the blood at any time.
- Earlier treatment
- People with a documented sustained virological response (HCV group) cannot join.
- Biomarker or test result
- HCV group: detectable plasma HCV RNA. HBV group: detectable plasma HBV RNA, and either no recorded HDV testing or a positive HDV serology.
Main reasons for not taking part
- No valid social insurance number (SVRN)
- No contact details available
- Documented sustained virological response (HCV group)
- Documented assessment of HDV status (HBV group)
Read by machine on 12 November 2026.
Where in Austria
- Department of Internal Medicine, Division of Gastroenterology and HepatologyGraz, AustriaContact: Vanessa Stadlbauer-Köllner, Univ. Prof. Dr.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Vanessa Stadlbauer-Koellner, MD
- Trial code
- NCT06834178
- Record updated
- 18 June 2026
- Original description
The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.Read full original descriptionShow less
Hepatitis Elimination And Liver Care in South-East Austria (HEAL-S)
The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.
Inclusion: The target population for the HCV cohort consists of individuals with detectable plasma HCV RNA at the latest observation; The target population for the HBV cohort consists of individuals with detectable plasma HBV RNA at any time and no recorded HDV testing or a positive HDV serology.
Exclusion: Documented Sustained Virological Response (HCV cohort); Documented assessment of HDV status (HBV cohort); No valid SVRN (german: Sozialversicherungsnummer, english: Social insurance number); No contact details available.